Navigation Links
OpGen recruits CEO to further gene-mapping business

Madison, Wis. The biotechnology firm OpGen hopes its new CEO will draw investment to its work in gene mapping, the company said on Monday. R.H. Joseph Shaw is the former CEO of medical firms Quantech and Cathra International.

I think Joe Shaw comes to OpGen with a good history of raising serious funds, and we hope he continues to do the same here, said Life Science Insights. OpGens technology may help identify the genes that result in the variability of patients response to therapy. This information may lead to better and......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 11/29/04


Related biology technology :

1. OpGen layoffs precede another funding round
2. OpGen forges agreement with Japanese importer
3. OpGen completes $5 million investment round
4. OpGen adds Thomas Pyle and James Ogle to board of directors
5. OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment
6. OpGen Creates Map of Worlds Most Lethal Fungus
7. OpGen Database Helps to Reduce Bioterrorist Threat
8. Better collaboration urged to further Wisconsin biotech
9. Johnson Controls jumping further into hybrid-vehicle battery world
10. While schools combat low tech enrollment, are businesses contributing to IT workforce woes?
11. CIOs focus on the business case while facing authority erosion
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2017)... and GREENWICH, Conn. , Feb. ... firm focused on venture growth investments in biotechnology ... Josh Richardson , M.D. to Managing Director. ... biotechnology companies.  He is a board observer at ... in Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... infusion of innovative telemedicine application, new and leading ... are experiencing a boom worldwide. The healthcare sector ... of technologies, services and new therapies for companies ... (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):